Researchers with the Kansas City Veterans Affairs Medical Center and North Dakota State University have designed a new way to deliver pancreatic cancer drugs that could make fighting
A new study has shown a novel peptide antagonist, given in combination with a PD-1 inhibitor, to be safe and well-tolerated in patients with advanced, refractory pancreatic and
A group of researchers funded by Neuroendocrine Tumor Research Foundation (NETRF) has discovered molecular information that may predict recurrence of non-functional pancreatic neuroendocrine tumors (pNETs), which do not
Maintenance treatment with the PARP inhibitor rucaparib (Rubraca) was well tolerated and provided clinical responses among patients with advanced BRCA- or PALB2-mutated pancreatic cancer sensitive to platinum-based chemotherapy,
Queen of Soul Aretha Franklin died today at age 76, her publicist confirmed to the Associated Press, after years of health troubles. People reported Monday that Franklin’s health had
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
